Camber appoints new president
PISCATAWAY, N.J. — The U.S. subsidiary of India-based generic drug maker Hetero Drugs has appointed Konstantin Ostaficiuk as its president, Camber said.
Ostaficiuk, who often goes by the nickname of Kon, succeeds Briggs Arrington, who has gone on to work for Hetero’s senior management team to find new opportunities for the company’s U.S. manufacturing operations. Ostaficiuk has worked in the generic drug industry for 25 years, having joined Camber in 2009 as VP sales and marketing.
“Camber and Hetero have a very robust pipeline and will continue to introduce and launch significant new products to our current portfolio in the remainder of 2011, 2012 and on into the future,” Ostaficiuk said. “We are committed to providing the highest level of quality and service available as we grow our business and our product line.”
Hi-Tech Pharmacal launches topical pain treatment
AMITYVILLE, N.Y. — The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.
The agency approved Hi-Tech’s sterile lidocaine jelly in the 2% strength, used for treating pain in procedures involving the urethra, painful urethritis and in endotracheal intubation.
Various versions of the drug had sales of $17 million in 2010, according to IMS Health.
Actavis’ generic Valtrex OKed by FDA
MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.
The FDA approved Actavis’ valacyclovir hydrochloride tablets in the 500-mg and 1-g strengths.
The drug is a generic version of GlaxoSmithKline’s Valtrex. Branded and generic forms of the drug had sales of about $1.5 billion in 2010, according to IMS Health.